Tert-butyl 4-[[4-(5-bromo-3-pyridinyl)-7-ethylpyrrolo[1,2-b]pyridazine-3-carbonyl]amino]piperidine-1-carboxylate
C25H30BrN5O3 — CID 91528272
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 4-[[4-(5-bromo-3-pyridinyl)-7-ethylpyrrolo[1,2-b]pyridazine-3-carbonyl]amino]piperidine-1-carboxylate
Tert-butyl 4-[[4-(5-bromo-3-pyridinyl)-7-ethylpyrrolo[1,2-b]pyridazine-3-carbonyl]amino]piperidine-1-carboxylate (PubChem CID 91528272) has the molecular formula C25H30BrN5O3 and a molecular weight of 528.45 g/mol. Its IUPAC name is tert-butyl 4-[[4-(5-bromo-3-pyridinyl)-7-ethylpyrrolo[1,2-b]pyridazine-3-carbonyl]amino]piperidine-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl 4-[[4-(5-bromo-3-pyridinyl)-7-ethylpyrrolo[1,2-b]pyridazine-3-carbonyl]amino]piperidine-1-carboxylate |
|---|---|
| PubChem CID | 91528272 |
| Molecular Formula | C25H30BrN5O3 |
| Molecular Weight | 528.45 g/mol |
| Exact Mass | 527.15 |
| IUPAC Name | tert-butyl 4-[[4-(5-bromo-3-pyridinyl)-7-ethylpyrrolo[1,2-b]pyridazine-3-carbonyl]amino]piperidine-1-carboxylate |
| SMILES | CCc1ccc2c(-c3cncc(Br)c3)c(C(=O)NC3CCN(C(=O)OC(C)(C)C)CC3)cnn12 |
| InChI | InChI=1S/C25H30BrN5O3/c1-5-19-6-7-21-22(16-12-17(26)14-27-13-16)20(15-28-31(19)21)23(32)29-18-8-10-30(11-9-18)24(33)34-25(2,3)4/h6-7,12-15,18H,5,8-11H2,1-4H3,(H,29,32) |
| InChIKey | SQKULLGURBQUNK-UHFFFAOYSA-N |
| XLogP | 4.85 |
| TPSA | 88.83 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 528.45 |
| LogP ≤ 5 | 4.85 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 91528272 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.